SEP 27, 2019 9:00 AM PDT

Investigating how Tpz-1 may be used as a novel therapeutic agent in the treatment of human hematologic cancers

Speaker
  • PhD Student, The University of Texas at El Paso (UTEP)
    Biography
      Jessica is a 2nd year PhD student at The University of Texas at El Paso. Jessica's research involves high-throughput screening of novel compounds for anticancer activity. She is currently focused on identifying the protein target of a potent compound that she found after screening more than 2,000 unique molecules. Most of Jessica's time in the lab is spent culturing various cancer and normal cell lines for use in cytotoxicity and mechanistic assays. The next step in her research is to analyze the transcriptome of cells treated with her compound to identify differentially expressed genes. Throughout the academic year, she also serves as a Teaching Assistant for undergraduate Biology lab courses. Outside of the lab, you can find Jessica working on science-themed stickers and stationery for her shop - Cell Kulture Co. Her mission is to encourage science-driven communication through art. She hopes that her colorful designs provide scientists an opportunity to engage in meaningful conversation about their research with non-experts. You can shop Jessica's current collection or inquire about custom orders at cellkultureco.com!

    Abstract
    DATE:  September 27, 2019
    TIME:   9:00am PT, 12:00pm ET
     
    Thienopyrazole derivatives have recently emerged as effective antitumoral agents with kinase inhibitory activity.  In this study, a novel thienopyrazole derivative with potent and selective in vitro cytotoxicity was identified in a high-throughput chemical library screening to identify novel anti-cancer drugs.  After 48 hours of exposure, compound Tpz-1 demonstrated potent and consistent cytotoxicity against a panel of human hematologic cells at nanomolar to low micromolar concentrations; an effect which was greatly diminished against the HS-27 non-cancerous foreskin fibroblast cell line.  Mechanistic analyses subsequently conducted against the CEM T-cell leukemia cell line revealed that Tpz-1 induces cell death via apoptosis and interferes with cell cycle progression in a dose-dependent manner.  These findings merit the further development of Tpz-1 as a novel therapeutic agent in the treatment of human hematologic cancers.
     
    In this webinar you will learn:
    • to investigate the mechanism, Tpz-1, through a series of apoptosis assays and a transcriptome analysis
    • Tpz-1 activity against leukemia and lymphoma cell lines and normal cell types.
     
     
     
     
    Webinars will be available for unlimited on-demand viewing after live event.
     
    LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.

    Show Resources
    You May Also Like
    MAY 11, 2021 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    MAY 11, 2021 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
    JUN 09, 2021 7:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    JUN 09, 2021 7:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Date: June 9, 2021 Time: 09 June 2021, 7am PDT, 10am EDT, 4pm CEST cells with dramatic implications on the validity of past cell culture related research. The fact that at least 509 cell lin...
    DEC 02, 2020 8:00 AM PST
    C.E. CREDITS
    DEC 02, 2020 8:00 AM PST
    DATE: December 2nd, 2020 TIME: 08:00am PDT, 11:00pm EDT Bioreactors and shakers are used to cultivate microorganisms, plant, insect, and mammalian cells in different volumes. Upscaling of pr...
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    NOV 16, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 16, 2020 8:00 AM PST
    Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
    OCT 29, 2020 6:00 AM PDT
    C.E. CREDITS
    OCT 29, 2020 6:00 AM PDT
    Date: October 29, 2020 Time: 6:00am (PDT), 9:00am (EDT), Chronic inflammation can occur as a result of a combination of genetic predispositions and environmental factors. Epigenetic modifica...
    SEP 27, 2019 9:00 AM PDT

    Investigating how Tpz-1 may be used as a novel therapeutic agent in the treatment of human hematologic cancers


    Specialty

    Molecular Biology

    Cancer Research

    Cell Biology

    Immunology

    Biotechnology

    Genetics

    Cell Culture

    Cancer Therapeutics

    Molecular Diagnostics

    Microbiology

    Biochemistry

    Dna

    Clinical Diagnostics

    Infectious Disease

    Biomarkers

    Geography

    North America56%

    Asia18%

    Europe15%

    South America4%

    Africa4%

    Oceania1%

    Registration Source

    Website Visitors52%

    Email Promotions33%

    Trending Newsletter Promotion4%

    WAVE Newsletter Promotion2%

    Social Media Promotions1%

    Other8%

    Job Title

    Student22%

    Research Scientist19%

    Educator/Faculty13%

    Medical Laboratory Technician8%

    Clinical Laboratory Scientist6%

    Medical Doctor/Specialist5%

    Executive5%

    Lab Management3%

    Post Doc3%

    Facility/Department Manager3%

    Scientist3%

    Biologist3%

    Pathologist2%

    Chemist2%

    Marketing/Sales2%

    Engineer1%

    Consultant1%

    Organization

    Academic Institution38%

    Hospital12%

    Clinical Laboratory10%

    Government5%

    Biotech Company4%

    Non-Profit Organization4%

    Medical Center3%

    Medical School3%

    Research Institute2%

    Life Science Company2%

    Private Practice1%

    Pharmaceutical Company1%

    Consultant1%

    Manufacturer - Other1%

    Other3%


    Show Resources
    Loading Comments...
    Show Resources
    Attendees
    • See more